Drug Manufacturers Move To Dismiss ‘Extraneous’ Claims In GLP-1 MDL
PHILADELPHIA — The manufacturers of diabetes and diet drugs that consumers allege cause gastrointestinal and other injuries moved to dismiss certain claims from a master long-form complaint against the drug manufacturers...To view the full article, register now.
Already a subscriber? Click here to view full article